214 related articles for article (PubMed ID: 21864238)
21. A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds.
Bertrand B; Casini A
Dalton Trans; 2014 Mar; 43(11):4209-19. PubMed ID: 24225667
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.
Gambini V; Tilio M; Maina EW; Andreani C; Bartolacci C; Wang J; Iezzi M; Ferraro S; Ramadori AT; Simon OC; Pucciarelli S; Wu G; Dou QP; Marchini C; Galassi R; Amici A
Eur J Med Chem; 2018 Jul; 155():418-427. PubMed ID: 29906688
[TBL] [Abstract][Full Text] [Related]
23. Organogold(III)-dithiocarbamate compounds and their coordination analogues as anti-tumor and anti-leishmanial metallodrugs.
de Andrade Querino AL; de Sousa AM; Thomas SR; de Lima GM; Dittz D; Casini A; do Monte-Neto RL; Silva H
J Inorg Biochem; 2023 Oct; 247():112346. PubMed ID: 37536162
[TBL] [Abstract][Full Text] [Related]
24. Comparative biological evaluation and G-quadruplex interaction studies of two new families of organometallic gold(I) complexes featuring N-heterocyclic carbene and alkynyl ligands.
Meier-Menches SM; Aikman B; Döllerer D; Klooster WT; Coles SJ; Santi N; Luk L; Casini A; Bonsignore R
J Inorg Biochem; 2020 Jan; 202():110844. PubMed ID: 31739113
[TBL] [Abstract][Full Text] [Related]
25. Gold(III) Complexes for Antitumor Applications: An Overview.
Bertrand B; Williams MRM; Bochmann M
Chemistry; 2018 Aug; 24(46):11840-11851. PubMed ID: 29575433
[TBL] [Abstract][Full Text] [Related]
26. Potential of Gold Candidates against Human Colon Cancer.
Abbasi M; Yaqoob M; Haque RA; Iqbal MA
Mini Rev Med Chem; 2021; 21(1):69-78. PubMed ID: 32767935
[TBL] [Abstract][Full Text] [Related]
27. Novel Gold(I) Thiolate Derivatives Synergistic with 5-Fluorouracil as Potential Selective Anticancer Agents in Colon Cancer.
Atrián-Blasco E; Gascón S; Rodrı Guez-Yoldi MJ; Laguna M; Cerrada E
Inorg Chem; 2017 Jul; 56(14):8562-8579. PubMed ID: 28682069
[TBL] [Abstract][Full Text] [Related]
28. Imidazole-based phosphane gold(I) complexes as potential agents for cancer treatment: synthesis, structural studies and antitumour activity.
Kunz PC; Kassack MU; Hamacher A; Spingler B
Dalton Trans; 2009 Oct; (37):7741-7. PubMed ID: 19759948
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies.
González-Barcia LM; Fernández-Fariña S; Rodríguez-Silva L; Bermejo MR; González-Noya AM; Pedrido R
J Inorg Biochem; 2020 Feb; 203():110931. PubMed ID: 31786438
[TBL] [Abstract][Full Text] [Related]
30. Protein targets for anticancer gold compounds: mechanistic inferences.
Gabbiani C; Messori L
Anticancer Agents Med Chem; 2011 Dec; 11(10):929-39. PubMed ID: 21864237
[TBL] [Abstract][Full Text] [Related]
31. Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.
Urig S; Fritz-Wolf K; Réau R; Herold-Mende C; Tóth K; Davioud-Charvet E; Becker K
Angew Chem Int Ed Engl; 2006 Mar; 45(12):1881-6. PubMed ID: 16493712
[No Abstract] [Full Text] [Related]
32. Anticancer Gold N-Heterocyclic Carbene Complexes: A Comparative in vitro and ex vivo Study.
Estrada-Ortiz N; Guarra F; de Graaf IAM; Marchetti L; de Jager MH; Groothuis GMM; Gabbiani C; Casini A
ChemMedChem; 2017 Sep; 12(17):1429-1435. PubMed ID: 28741878
[TBL] [Abstract][Full Text] [Related]
33. Highly cytotoxic gold(i)-phosphane dithiocarbamate complexes trigger an ER stress-dependent immune response in ovarian cancer cells.
Le HV; Babak MV; Ehsan MA; Altaf M; Reichert L; Gushchin AL; Ang WH; Isab AA
Dalton Trans; 2020 Jun; 49(22):7355-7363. PubMed ID: 32432621
[TBL] [Abstract][Full Text] [Related]
34. Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs.
Bagowski CP; You Y; Scheffler H; Vlecken DH; Schmitz DJ; Ott I
Dalton Trans; 2009 Dec; (48):10799-805. PubMed ID: 20023909
[TBL] [Abstract][Full Text] [Related]
35. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
36. Gold Drugs with {Au(PPh
Stenger-Smith JR; Mascharak PK
ChemMedChem; 2020 Nov; 15(22):2136-2145. PubMed ID: 33025735
[TBL] [Abstract][Full Text] [Related]
37. Time-dependent density functional theory study of the luminescence properties of gold phosphine thiolate complexes.
Guidez EB; Aikens CM
J Phys Chem A; 2015 Apr; 119(14):3337-47. PubMed ID: 25793466
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of polymeric gold glyco-conjugates as anti-cancer agents.
Ahmed M; Mamba S; Yang XH; Darkwa J; Kumar P; Narain R
Bioconjug Chem; 2013 Jun; 24(6):979-86. PubMed ID: 23631753
[TBL] [Abstract][Full Text] [Related]
39. New selective thiolate gold(i) complexes inhibit the proliferation of different human cancer cells and induce apoptosis in primary cultures of mouse colon tumors.
Abas E; Pena-Martinez R; Aguirre-Ramírez D; Rodriguez-Dieguez A; Laguna M; Grasa L
Dalton Trans; 2020 Feb; 49(6):1915-1927. PubMed ID: 31971194
[TBL] [Abstract][Full Text] [Related]
40. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
